Biotech · Private company
Vividion Therapeutics, Inc.
Track this companyFree. Adds Vividion Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials54 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- PembrolizumabPhase 2 · Colorectal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- VVD-133214Phase 2 · Colorectal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- SotorasibPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TrametinibPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- VVD-130037Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- VVD-130850Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- VVD-133214Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- VVD-159642Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or RectumPHASE2 · RECRUITING · started Sep 11, 2026ClinicalTrials.gov NCT07811193 · fetched Nov 12, 2026
- A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Feb 25, 2025ClinicalTrials.gov NCT06804824 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Jan 25, 2024ClinicalTrials.gov NCT06004245 · fetched Nov 12, 2026
- A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic TumorsPHASE1 · TERMINATED · started Jan 5, 2024ClinicalTrials.gov NCT06188208 · fetched Nov 12, 2026
- A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Jul 28, 2023ClinicalTrials.gov NCT05954312 · fetched Nov 12, 2026